Please use this identifier to cite or link to this item: https://biore.bio.bg.ac.rs/handle/123456789/1108
DC FieldValueLanguage
dc.contributor.authorPejić, Snežanaen_US
dc.contributor.authorTodorović, Anaen_US
dc.contributor.authorStojiljković, Vesnaen_US
dc.contributor.authorCvetković, Draganaen_US
dc.contributor.authorLučić, Nenaden_US
dc.contributor.authorRadojičić, Ratkoen_US
dc.contributor.authorSaičić, Zoricaen_US
dc.contributor.authorPajović, Snežanaen_US
dc.date.accessioned2019-07-24T12:28:16Z-
dc.date.available2019-07-24T12:28:16Z-
dc.date.issued2008-09-01-
dc.identifier.issn0001-3765-
dc.identifier.urihttps://biore.bio.bg.ac.rs/handle/123456789/1108-
dc.description.abstractEpidemiological and experimental data point to involvement of oxygen derived radicals in the pathogenesis of gynecological disorders, as well as in cancer development. The objective of the present study was to examine changes in activities and levels of copper/zinc superoxide dismutase (CuZnSOD) and lipid hydroperoxides (LOOH) in blood and endometrial tissue of patients diagnosed with uterine myoma, endometrial polypus, hyperplasia simplex, hyperplasia complex and adenocarcinoma endometrii. The results of our study have shown decreased SOD activities and unchanged SOD protein level in blood of all examined patients in comparison to healthy subjects. Decrease of both SOD activity and level was found in endometrium of patients with hyperplasia simplex, hyperplasia complex and adenocarcinoma in comparison to women with polypus or myoma. LOOH level was elevated in both tissues of patients with hyperplasia or adenocarcinoma in comparison to healthy subjects or patients with benign diagnosis. Our findings suggest that the decrease in SOD activity and level, as well as the increase in LOOH level, in patients with gynecological disorders, render these patients more susceptible to oxidative damage caused by reactive oxygen species (ROS). An imbalance in ROS formation and SOD level may be important in the pathogenesis and/or perpetuation of tissue damage in gynecological patients. Since evidence suggests that SOD may be a therapy target for cancer treatment, our findings provide a basis for further research and options for clinical applications.en_US
dc.language.isoenen_US
dc.relation.ispartofAnais da Academia Brasileira de Cienciasen_US
dc.subjectCopper/zinc superoxide dismutaseen_US
dc.subjectEndometrial adenocarcinomaen_US
dc.subjectEndometrial hyperplasiaen_US
dc.subjectEndometrial polypusen_US
dc.subjectLipid hydroperoxidesen_US
dc.subjectUterine myomaen_US
dc.titleSuperoxide dismutase and lipid hydroperoxides in blood and endometrial tissue of patients with benign, hyperplastic and malignant endometriumen_US
dc.typeArticleen_US
dc.identifier.pmid18797802-
dc.identifier.scopus2-s2.0-51749113114-
dc.identifier.urlhttps://api.elsevier.com/content/abstract/scopus_id/51749113114-
item.languageiso639-1en-
item.cerifentitytypePublications-
item.openairetypeArticle-
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
crisitem.author.deptChair of Genetics and Evolution-
crisitem.author.orcid0000-0002-1311-7481-
Appears in Collections:Journal Article
Show simple item record

SCOPUSTM   
Citations

22
checked on Nov 16, 2024

Page view(s)

1
checked on Nov 21, 2024

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.